Written by Thomas Greene.
Pfizer Inc. faces a serious scandal. Former employees, including top executives, have come forward to expose what they describe as the company’s sinister agenda. Their consciences couldn’t let them stay silent any longer, as they allege Pfizer’s primary goal is to profit from public health crises.
Dr. Peter Rost, a former Pfizer Vice President turned whistleblower, claims to have proof that Pfizer intentionally designed their vaccines to cause widespread heart disease and aggressive cancers, creating a lucrative market of long-term patients. Dr. Rost, author of “The Whistleblower: Confessions of a Healthcare Hitman,” first gained attention in 2007 when he testified before the Senate about Big Pharma’s exploitative practices.
Rost’s journey from a high-ranking executive to a whistleblower was tumultuous. He faced legal battles, defamation, and financial ruin. Reflecting on his experience, Rost compared Big Pharma to the mob, stating, “When you’re talking to the drug industry, you end up never working again.”
Vaccine Concerns and Market Manipulation
Dr. Rost’s latest allegations suggest that pharmaceutical companies operate with a mafia-like mentality, not just in handling whistleblowers but also in their public dealings. According to him, Big Pharma companies design vaccines to keep people ill, maximizing profits. “A patient cured is a patient lost,” Rost remarked, underscoring the alleged strategy behind these business practices.
The claims against Pfizer have intensified with the advent of the COVID-19 vaccine. Reports of heart issues and aggressive cancers, dubbed “turbo cancer,” have surged globally. Dr. Rost insists that Pfizer is capitalizing on these health crises, as evidenced by their strategic acquisitions.
In December 2021, Pfizer announced the purchase of Arena Pharmaceuticals for $6.7 billion, primarily to acquire etrasimod, a drug for ulcerative colitis. Critics argue that the high price tag indicated Pfizer’s desperation, driven by the drug’s potential use in treating heart inflammation, a side effect linked to mRNA vaccines.
Strategic Acquisitions Raise Eyebrows
In early 2023, Pfizer’s $43 billion purchase of Seagen Pharmaceuticals, known for its cancer drugs, further fueled speculation. CEO Albert Bourla described it as “acquiring the goose that is laying the golden eggs,” betting on a surge in cancer cases. The timing was suspicious, as the term “turbo cancer” emerged, describing unusually aggressive cancers following COVID-19 booster shots.
Mike Yeadon, another former Pfizer VP and worldwide head of research, supports Rost’s claims, alleging that the company’s actions are part of a broader plan. According to Yeadon, Pfizer’s business moves aren’t merely opportunistic but are part of a deliberate strategy to generate profit from widespread illness.
Government and Legal Implications
Understanding the role of government is crucial to grasping how Big Pharma could execute such a scheme. Robert F. Kennedy Jr. explains that the pharmaceutical industry secured immunity from liability by convincing the government that vaccines are “unavoidably unsafe.” This legal shield has emboldened companies like Pfizer, despite mounting evidence of harm.
However, legal immunity may not protect Pfizer from financial ruin. Multiple U.S. states, including Texas, Utah, Kansas, Mississippi, and Louisiana, are suing Pfizer for allegedly concealing the risks associated with their vaccine, such as myocarditis, pericarditis, and failed pregnancies. With more states expected to follow, Pfizer could face a fate similar to Purdue Pharma, which was brought down by lawsuits over its harmful products.
Our Take
The allegations against Pfizer, as detailed by Dr. Rost and others, paint a troubling picture of corporate greed prioritizing profits over public health. If true, these actions represent a severe betrayal of public trust. The potential for Pfizer to face significant legal consequences, including bankruptcy, underscores the gravity of the situation. It’s imperative that transparency and accountability prevail to protect public health and restore faith in the medical industry.
